MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2174/0109298673352893241228015939

Медицинская библиотека · Current medicinal chemistry · 2026

Oridonin Suppresses the Malignant Progression of Lung Cancer by Targeting S100A11.

Luo Yulin, Li Jingjing, Chen Yao, Huang Yan, Luo Qi, Luo Qiang, Huang Qingqing, Huang Gang, Jin Mingming

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Lung cancer (LC) is the second most lethal cancer and efficient treatments are missing. Our understanding of the underlying pathogenic mechanisms remains limited. Oridonin is a compound extracted from the Chinese herb Rabdosia rubescens with anticancer properties. Nevertheless, its effects on LC and the underlying mechanisms remain unknown.

METHODS

In the current research, A549 and Hcc1833 cells were treated with different doses of oridonin, and cell proliferation and migration were detected using CCK8, EdU, Transwell, and wound healing assays. A subcutaneous tumor and caudal vein metastasis model was generated to verify the inhibitory effects of oridonin on Hcc1833 tumor growth and metastasis in vivo. Proteomics analyses then were performed to examine the regulatory mechanism. LiP-SMap combined with microscale thermophoresis and molecular docking analyses were used to validate the relationship between oridonin and S100A11.

RESULTS

Data showed that oridonin suppressed cell proliferation and migration depending on dose and suppressed tumor growth and invasion. LiP-SMap and molecular docking analyses confirmed that oridonin interacted with the Asn-53 residue of S100A11, which inhibited the activation of oridonin. S100A11 overexpression reversed the inhibitory effects of oridonin on cell proliferation and migration.

CONCLUSION

In conclusion, the data indicate that oridonin suppresses LC malignant progression by targeting S100A11.

Для цитирования: Luo Yulin, Li Jingjing, Chen Yao, Huang Yan, Luo Qi, Luo Qiang, Huang Qingqing, Huang Gang, Jin Mingming. Oridonin Suppresses the Malignant Progression of Lung Cancer by Targeting S100A11.. Current medicinal chemistry. 2026. DOI: 10.2174/0109298673352893241228015939.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.